NO20001341L - Modulering av immunresponser - Google Patents

Modulering av immunresponser

Info

Publication number
NO20001341L
NO20001341L NO20001341A NO20001341A NO20001341L NO 20001341 L NO20001341 L NO 20001341L NO 20001341 A NO20001341 A NO 20001341A NO 20001341 A NO20001341 A NO 20001341A NO 20001341 L NO20001341 L NO 20001341L
Authority
NO
Norway
Prior art keywords
group
animal
well
modulation
immune responses
Prior art date
Application number
NO20001341A
Other languages
English (en)
Other versions
NO20001341D0 (no
Inventor
Carl John Landauer
Gabriel Johannes Du Preez
Volker Reinhard Schillack
Derrick Cecil Attfield
Johannes Beyers Van Bogaarden
Original Assignee
Frangold Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frangold Holdings Ltd filed Critical Frangold Holdings Ltd
Publication of NO20001341D0 publication Critical patent/NO20001341D0/no
Publication of NO20001341L publication Critical patent/NO20001341L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En fremgangsmåte ved påvirkning eller modulering for stimu-lering eller supresjon av immuncelleprodukter etter en im-munrespons til en ekstern eller endogen immunstimulant hos et dyr omfattende trinnene å administrere til et slikt dyr en ikke-toksisk immunmodulerende effektiv mengde av en for-bindelse valgt fra gruppen omfattende forbindelser av den generelle kjemiske formel (I) RCO-NRRhvor Rj er valgt fra gruppen omfattende H og lavere [det vil si Ctil C. alkyl og C, til Calkenylgrupper; R, og Rer like eller forskjellige og hver er valgt fra gruppen omfattende H, lavere [det vil si Ctil C] alkyl og Ctil Calkenylgrup-. per som eventuelt kan være halogenert eller hydroksylert, eller som kan, i kombinasjon med hverandre danne en -. (CH)-gruppe hvor n er et tall fra 2 til 5, eller gruppen. -(CHj) j-0-(CHj) j samt metabolitter og prodroger derav.remgangsmåten er nyttig ved behandling av en rekke sykdom-:^ mer som er assosiert med uriktige immunresponser og det er beskrevet anvendelser av forbindelser av formel (I) ved - fremstilling av medikamenter for anvendelse ved behandlin-. gen av slike sykdommer samt for farmasøytiske preparater inneholdende slike.
NO20001341A 1997-09-16 2000-03-15 Modulering av immunresponser NO20001341L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA978319 1997-09-16
PCT/US1998/019126 WO1999013885A1 (en) 1997-09-16 1998-09-16 Modulation of immune responses

Publications (2)

Publication Number Publication Date
NO20001341D0 NO20001341D0 (no) 2000-03-15
NO20001341L true NO20001341L (no) 2000-05-16

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001341A NO20001341L (no) 1997-09-16 2000-03-15 Modulering av immunresponser

Country Status (10)

Country Link
EP (1) EP1019063A4 (no)
JP (1) JP2001516721A (no)
CN (1) CN1279612A (no)
AU (1) AU737867B2 (no)
BR (1) BR9812321A (no)
CA (1) CA2304119A1 (no)
IL (1) IL135091A0 (no)
NO (1) NO20001341L (no)
NZ (1) NZ503418A (no)
WO (1) WO1999013885A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (en) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited A substance or composition for the treatment of cancer
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Also Published As

Publication number Publication date
NZ503418A (en) 2001-02-23
IL135091A0 (en) 2001-05-20
AU9389098A (en) 1999-04-05
CN1279612A (zh) 2001-01-10
NO20001341D0 (no) 2000-03-15
EP1019063A1 (en) 2000-07-19
WO1999013885A1 (en) 1999-03-25
AU737867B2 (en) 2001-09-06
BR9812321A (pt) 2000-09-05
JP2001516721A (ja) 2001-10-02
CA2304119A1 (en) 1999-03-25
EP1019063A4 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
ATE195740T1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
JPS5412381A (en) N-alkylpiperidine derivative
AU636738B2 (en) Nematicidal compositions
NO174952C (no) Fremgangsmåte ved fremstilling av et oralt, farmasöytisk preparat som er stabilt mot misfarging og som inneholder en syrelabil forbindelse
NO20003514L (no) Hypolipidemiske benzothiazepin-forbindelser
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
HUT54705A (en) Process for producing 11 beta-aryl-4-estrenes and pharmaceutical compositions comprising same
NO971625L (no) Nye peptider med immunomodulatoriske effekter
ES8202031A1 (es) Procedimiento para la obtencion de derivados de piranosa
AU6748081A (en) 3,4,5-trihydroxy piperidines
AU580729B2 (en) Chromene derivatives
DE3866072D1 (de) Pestizide biosynthetische produkte enthaltende zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung.
DE69116237D1 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
NO900741L (no) Fremgangsmaate for syntetisering av tris-hydroxymethyl-lavere-alkanestere som fettimitasjoner.
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
NO20001341L (no) Modulering av immunresponser
AU1413788A (en) Dihydropyridinamides process for their preparation, and their use in medicaments
HU901193D0 (en) Process for protection against phytopathogenic bacteria using phosphonic acid derivatives
DK119188D0 (da) Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne
ES8800217A1 (es) Procedimiento para la preparacion de acidos 4-(isoxazolil)-tiazol-2-oxamicos y sus derivados
ES8609482A1 (es) Un metodo para producir acido dihidrodesoxigriseolico y sa- les y esteres del mismo
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application